You have 9 free searches left this month | for more free features.

neoplasm, granular and epithelial

Showing 1 - 25 of 2,453

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • +8 more
  • AB-1015
  • Iowa City, Iowa
    U. of Iowa Health Care
Jan 30, 2023

Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

Completed
  • Carcinoma
  • +12 more
  • Ocoxin-Viusid
  • Havana, Cuba
    National Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022

Metastatic Cancer, Epithelial Tumor Trial in United States (NG-641)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641
  • Los Angeles, California
  • +5 more
Jan 16, 2023

Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

Not yet recruiting
  • Ovarian Cancer
  • +5 more
  • MIRRORS Protocol
  • Standard Open Cytoreductive Surgery
  • (no location specified)
Jul 17, 2023

Tumor Recurrence, Malignant Epithelial Tumor of Vulva, Malignant Epithelial Tumor of Ovary Trial in Pavia (carbon ion radiation

Recruiting
  • Tumor Recurrence
  • +3 more
  • carbon ion radiation therapy
  • Pavia, Pv, Italy
    CNAO
Jul 13, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Ovarian Tumor Epithelial Trial (acute normovolemic hemodilution (ANH), acute hypervolemic hemodilution (AHH))

Completed
  • Ovarian Neoplasm Epithelial
  • acute normovolemic hemodilution (ANH)
  • acute hypervolemic hemodilution (AHH)
  • (no location specified)
Oct 21, 2023

Metastatic Cancer, Epithelial Tumor Trial in Santa Monica, Liverpool, Oxford (NG-641 in combination with Nivolumab)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641 in combination with Nivolumab
  • Santa Monica, California
  • +2 more
Mar 16, 2022

Ovarian Tumor Epithelial, Ovarian Cancer, Fallopian Tube Tumors Trial in India (Oregovomab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Ovarian Neoplasm Epithelial
  • +4 more
  • Oregovomab
  • +3 more
  • Visakhapatnam, Andhra Pradesh, India
  • +7 more
Dec 7, 2022

Endocrine Disruptors and Life STILe in Breast Cancer Development

Recruiting
  • Breast Cancer
  • +5 more
    • Roma, Italy
      Alessandra Fabi
    Feb 25, 2023

    Ovarian Cancer, Drug Related Tumor/Cancer Trial (secondary cytoreductive surgery, chemo)

    Not yet recruiting
    • Ovarian Cancer
    • Drug Related Neoplasm/Cancer
    • (no location specified)
    Jan 28, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Carcinoma, Neoplasia; Intraepithelial, Cervix, Glandular Tumors Trial in Havana (Glizigen® + Ocoxin-Viusid®)

    Recruiting
    • Carcinoma
    • +4 more
    • Glizigen® + Ocoxin-Viusid®
    • Havana, Cuba
      Our Lady of Rule No. 52 &/Remedios and Quiroga, Luyano
    Jul 5, 2022

    Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +7 more
    • Atlanta, Georgia
    • +2 more
    Nov 3, 2022

    Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

    Not yet recruiting
    • Ovarian Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023

    Malignant Tumor of Ovary, Malignant Tumor of Fallopian Tube, Malignant Tumor of Peritoneum Trial in Charlotte, Cleveland

    Completed
    • Malignant Neoplasm of Ovary
    • +2 more
    • Diagnostic laparoscopy
    • Charlotte, North Carolina
    • +1 more
    Mar 11, 2022

    ResiduAl Cancer With Liquid Biopsy Evaluation

    Recruiting
    • Bladder Carcinoma
    • +14 more
    • Guardant Reveal
    • Redwood City, California
      Redwood City
    Sep 7, 2022

    Improved Diagnosis of Ovarian Cancer

    Recruiting
    • Ovarian Neoplasms
    • +6 more
      • Aarhus, Denmark
        Department of Gynaecology and Obstetrics, Aarhus University Hosp
      May 1, 2023

      Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

      Recruiting
      • Ovarian Cancer
      • +68 more
      • Phoenix, Arizona
      • +8 more
      Aug 18, 2022

      Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed

      Completed
      • Ovarian Neoplasm
      • +4 more
        • (no location specified)
        Aug 22, 2022

        Sarcomas, Melanomas, Germ Cell Tumors Trial run by the NCI (AeroEclipse II Breath Actuated Nebulizer, Bintrafusp alfa,

        Withdrawn
        • Sarcomas
        • +4 more
        • AeroEclipse II Breath Actuated Nebulizer
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 16, 2021

        Patients With Low Grade Ovarian or Peritoneal Tumors

        Recruiting
        • Low Grade Ovarian Serous Adenocarcinoma
        • +5 more
        • Biospecimen Collection
        • Electronic Health Record Review
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 18, 2022

        Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt

        Unknown status
        • Esophageal Neoplasms
        • +2 more
        • Endoscopic ultrasound
        • Kafr Ash Shaykh, Kafrelsheikh, Egypt
          Kafrelsheikh University
        Aug 30, 2021

        Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,

        Not yet recruiting
        • Solid Tumors
        • +8 more
        • Magnetic Resonance-Guided High Intensity Focused Ultrasound
        • Lyso-thermosensitive Liposomal Doxorubicin
        • (no location specified)
        Mar 10, 2022

        Ovarian Cancer, Endometrial Cancer, Ovary Tumor Trial in Multiple Locations (Physician's choice according to patient's needs.)

        Recruiting
        • Ovarian Cancer
        • +6 more
        • Physician's choice according to patient's needs.
        • Multiple Locations, Germany
          Multiple sites all over Germany
        Dec 1, 2021